Journal article
The shortcomings of COVID-19 testing in Ecuador: time to incentivize research and innovation
- Abstract:
- The COVID-19 pandemic hit Ecuador severely. The country caught the attention of international media due to its high death toll and overwhelmed healthcare system. The clinical diagnostics system was rapidly overloaded, and the import of PCR tests was delayed. The case of Ecuador illustrates how middle-income countries rely heavily on the importation of biotechnological products for their healthcare systems. The Ecuadorian experience during the COVID-19 pandemic serves as a call for the formation of policies for the development of the biotechnological industry.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 693.5KB, Terms of use)
-
- Publisher copy:
- 10.3390/life12030325
Authors
- Publisher:
- MDPI
- Journal:
- Life More from this journal
- Volume:
- 12
- Issue:
- 3
- Article number:
- 325
- Publication date:
- 2022-02-22
- Acceptance date:
- 2022-02-09
- DOI:
- EISSN:
-
2075-1729
- Pmid:
-
35330076
- Language:
-
English
- Keywords:
- Pubs id:
-
1308876
- Local pid:
-
pubs:1308876
- Deposit date:
-
2023-11-09
- ARK identifier:
Terms of use
- Copyright holder:
- Chalen et al.
- Copyright date:
- 2022
- Rights statement:
- Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record